Name | methyl (2R)-2-[(2-chloro-5-nitropyrimidin-4-yl)-cyclopentylamino]butanoate |
---|
Molecular Formula | C14H19ClN4O4 |
---|---|
Molecular Weight | 342.77800 |
Exact Mass | 342.10900 |
PSA | 101.14000 |
LogP | 3.26200 |
HS Code | 2933599090 |
---|
~72% 755039-53-3 |
Literature: SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.; JIANGSU HENGRUI MEDICINE CO., LTD. Patent: US2012/184543 A1, 2012 ; Location in patent: Page/Page column 24 ; |
~% 755039-53-3 |
Literature: ELAN PHARMACEUTICALS, INC.; GALEMMO, Robert, A., Jr.; ARTIS, Dean, Richard; YE, Xiaocong, Michael; AUBELE, Danielle, L.; TRUONG, Anh, P.; BOWERS, Simeon; HOM, Roy, K.; ZHU, Yong-Liang; NEITZ, R., Jeffrey; SEALY, Jennifer; ADLER, Marc; BEROZA, Paul; ANDERSON, John, P. Patent: WO2011/79114 A1, 2011 ; WO 2011/079114 A1 |
Precursor 2 | |
---|---|
DownStream 3 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |